Pages that link to "Q33845739"
Jump to navigation
Jump to search
The following pages link to Drug screening in a zebrafish model of Duchenne muscular dystrophy. (Q33845739):
Displaying 50 items.
- Defects of the Glycinergic Synapse in Zebrafish (Q26738425) (← links)
- Model organisms in the fight against muscular dystrophy: lessons from drosophila and Zebrafish (Q26991681) (← links)
- Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies. (Q27028125) (← links)
- Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery (Q27144251) (← links)
- Dasatinib as a treatment for Duchenne muscular dystrophy (Q27300846) (← links)
- A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish (Q27322025) (← links)
- Hanging on for the ride: adhesion to the extracellular matrix mediates cellular responses in skeletal muscle morphogenesis and disease (Q28087402) (← links)
- Zebrafish chemical screening reveals the impairment of dopaminergic neuronal survival by cardiac glycosides (Q28482588) (← links)
- Recent advances using zebrafish animal models for muscle disease drug discovery (Q28551915) (← links)
- Characterization of Zebrafish Models of Marinesco-Sjögren Syndrome (Q28553053) (← links)
- Applications of chemogenomic library screening in drug discovery (Q28656335) (← links)
- Using Touch-evoked Response and Locomotion Assays to Assess Muscle Performance and Function in Zebrafish (Q28817560) (← links)
- Bridging integrator 1 (Bin1) deficiency in zebrafish results in centronuclear myopathy (Q30580169) (← links)
- NAD biosynthesis ameliorates a zebrafish model of muscular dystrophy (Q31105806) (← links)
- PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy (Q33987140) (← links)
- Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy (Q33991780) (← links)
- The developing zebrafish (Danio rerio): A vertebrate model for high‐throughput screening of chemical libraries (Q34024345) (← links)
- The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish (Q34087155) (← links)
- High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding (Q34262912) (← links)
- Dystrophin is a tumor suppressor in human cancers with myogenic programs (Q34479070) (← links)
- Zebrafish based small molecule screens for novel DMD drugs (Q34706642) (← links)
- High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics (Q34792390) (← links)
- Regio- and stereoselective synthesis of spirooxindole 1'-nitro pyrrolizidines with five concurrent stereocenters under aqueous medium and their bioprospection using the zebrafish (Danio rerio) embryo model (Q34996666) (← links)
- Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. (Q35043351) (← links)
- A manual small molecule screen approaching high-throughput using zebrafish embryos (Q35158510) (← links)
- Identification of aggregation inhibitors of the human antibody light chain repertoire by phage display (Q35211434) (← links)
- ColVI myopathies: where do we stand, where do we go? (Q35290709) (← links)
- Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish. (Q35802879) (← links)
- Small zebrafish in a big chemical pond. (Q35951647) (← links)
- Porcine models of muscular dystrophy (Q35974809) (← links)
- Hooked! Modeling human disease in zebrafish (Q36068284) (← links)
- Zebrafish models flex their muscles to shed light on muscular dystrophies (Q36359190) (← links)
- Analysis of Zebrafish Larvae Skeletal Muscle Integrity with Evans Blue Dye. (Q36408382) (← links)
- Galanin regulates blood glucose level in the zebrafish: a morphological and functional study (Q36456375) (← links)
- Vascular-targeted therapies for Duchenne muscular dystrophy (Q36835180) (← links)
- MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation (Q37090136) (← links)
- Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A. (Q37307216) (← links)
- Force measurement during contraction to assess muscle function in zebrafish larvae. (Q37354921) (← links)
- Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1. (Q37438540) (← links)
- Membrane-myofibril cross-talk in myofibrillogenesis and in muscular dystrophy pathogenesis: lessons from the zebrafish (Q37522475) (← links)
- CRISPR/Cas9 in zebrafish: an efficient combination for human genetic diseases modeling (Q37586374) (← links)
- Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy. (Q37604365) (← links)
- Analysis of embryonic and larval zebrafish skeletal myofibers from dissociated preparations (Q37709161) (← links)
- Novel models for assessing blood-brain barrier drug permeation (Q37999058) (← links)
- Advances in zebrafish chemical screening technologies. (Q38050177) (← links)
- Duchenne muscular dystrophy drug discovery - the application of utrophin promoter activation screening (Q38087705) (← links)
- Neuromuscular disorders in zebrafish: state of the art and future perspectives. (Q38098929) (← links)
- Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy (Q38168509) (← links)
- Functional muscle ischemia in Duchenne and Becker muscular dystrophy (Q38175976) (← links)
- Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells. (Q38193799) (← links)